A multiplexed cell-based assay for antibody screening against cell surface receptors.

The use of monoclonal antibodies against a wide range of protein targets is an expanding area for the development of therapies and biomarkers of diseases such as cancer and autoimmune disorders.

 

Please click on the file in the right hand panel to download this Application Note.